Hao Shen

3.8k total citations · 1 hit paper
102 papers, 1.9k citations indexed

About

Hao Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hao Shen has authored 102 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 27 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Hao Shen's work include Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (16 papers) and Epigenetics and DNA Methylation (13 papers). Hao Shen is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (16 papers) and Epigenetics and DNA Methylation (13 papers). Hao Shen collaborates with scholars based in China, United States and Canada. Hao Shen's co-authors include Ari Melnick, Wendy Béguelin, Matt Teater, Olivier Elemento, María Teresa Calvo, Boqiang Liu, Liang Shi, Yifan Wang, Xiujun Cai and Yong Xia and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hao Shen

96 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription

2021 171 citations Qinjunjie Chen, Haibo Wang et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Hao Shen

Since Specialization

Citations

This map shows the geographic impact of Hao Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Shen more than expected).

Fields of papers citing papers by Hao Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Shen. The network helps show where Hao Shen may publish in the future.

Co-authorship network of co-authors of Hao Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Shen. A scholar is included among the top collaborators of Hao Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Shen. Hao Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head 2025 ·Open Medicine ·Bin Zuo, Zhanchao Wang, Hua Lu, Hao Shen	0
2	Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types 2024 ·(unknown), Hao Shen, (unknown), (unknown), (unknown), (unknown), Dawei Wang, (unknown), (unknown), Xiao Wang, Peng Yang	2
3	The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era 2024 ·Cancer Science ·Yifan Wu, Qunhui Yuan, Hao Shen, (unknown), (unknown), (unknown), Xinyu Zhang, Jia‐Zhu Wu, Rui Gao, Li Wang, Jianyong Li, Hua Yin, Jin‐Hua Liang, Wei Xu	1
4	CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway 2024 ·Functional & Integrative Genomics ·Xin Chen, Hao Shen, Huifang Liu, Liling Tan, (unknown)	1
5	Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy 2024 ·Clinical and Translational Medicine ·Wei Hua, Jie Liu, Yue Li, Hua Yin, Hao Shen, Jia‐Zhu Wu, Yilin Kong, (unknown), (unknown), (unknown), Li Wang, Jianyong Li, Rui Gao, Jin‐Hua Liang, Wei Xu	2
6	GGT5 as a promising prognostic biomarker and its effects on tumor cell progression in gastric cancer 2024 ·Translational Cancer Research ·Wenchao Chen, (unknown), Hao Shen, Jia Xu, Chen Jin, (unknown), Jian Xu, Bin Xu	1
7	WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer 2024 ·npj Precision Oncology ·(unknown), Xuefei Hu, Fuao Cao, Leqi Zhou, (unknown), Hao Shen, (unknown), Xiaoming Zhu, (unknown), Zixuan Liu, Guimin Wang, Guanyu Yu, Wenjun Chang, Wei Zhang	5
8	Acupuncture treatment of diabetic peripheral neuropathy: an overview of systematic reviews based on evidence mapping 2024 ·Frontiers in Neurology ·(unknown), Hao Shen, Yi Zhang, Yuanyuan Li, Yuanyuan Jing, (unknown), Hongli Wu, Yan‐Ming Xie, Huan Liu	1
9	LRP1 as a promising therapeutic target for gastrointestinal tumors: Inhibiting proliferation, invasion and migration of cancer cells 2023 ·Oncology Letters ·Mengying Zhu, Hao Shen, Bili Wang, (unknown), Jin Chen, Jun Ren, (unknown), Jian Xu	5
10	EDP-BGCNN: Effective Defect Prediction via BERT-based Graph Convolutional Neural Network 2023 ·Hao Shen, Xiaolin Ju, Xiang Chen, (unknown)	2
11	Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks 2022 ·Gastroenterology report ·Pinghua Yang, Fei Teng, (unknown), Yong Xia, (unknown), Zhangjun Cheng, Jun Li, Zhengqing Lei, Kui Wang, Baohua Zhang, Tian Yang, Xuying Wan, Hao Yin, Hao Shen, Timothy M. Pawlik, Wan Yee Lau, Zhiren Fu, (unknown)	5
12	Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma 2022 ·Cancers ·Xiao Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Hao Shen, (unknown), Dawei Wang, (unknown), Peng Yang	5
13	Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinoma 2022 ·Translational Cancer Research ·(unknown), Hao Shen	2
14	Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival 2021 ·Blood Cancer Discovery ·Meng Li, Matthew Teater, Jun Young Hong, Noel R. Park, Cihangir Duy, Hao Shen, Ling Wang, Zhengming Chen, Leandro Cerchietti, Shawn M. Davidson, Hening Lin, Ari Melnick	18
15	Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer 2021 ·Computational and Mathematical Methods in Medicine ·Hao Shen, Yong-Lian Guo, Guohao Li, Wei Zhao, (unknown)	3
16	Comprehensive Characterization of Common and Cancer-Specific Differently Expressed lncRNAs in Urologic Cancers 2021 ·Computational and Mathematical Methods in Medicine ·(unknown), (unknown), (unknown), Zhongjun Chen, (unknown), (unknown), Hao Shen	6
17	Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription breakdown → 2021 ·Journal of Hepatology ·Qinjunjie Chen, Haibo Wang, Zheng Li, Fengwei Li, Leilei Liang, Yiran Zou, Hao Shen, Jun Li, Yong Xia, Zhangjun Cheng, Tian Yang, Kui Wang, Feng Shen	171
18	FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer 2020 ·SHILAP Revista de lepidopterología ·(unknown), Gaopi Deng, Yue Fu, Yang Han, (unknown), Lixue Yin, Cai Chen, Hao Shen, (unknown), Shuai Zeng	5
19	EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop 2017 ·Nature Communications ·Wendy Béguelin, Martín A. Rivas, María Teresa Calvo, Matt Teater, Alberto Purwada, David Redmond, Hao Shen, (unknown), Olivier Elemento, Ankur Singh, Ari Melnick	129
20	Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women 2008 ·Carcinogenesis ·Jie Liang, Peng Chen, Zhiqing Hu, Xiaoyi Zhou, Lujia Chen, Mingqiang Li, Yanfang Wang, Jin Tang, H. Wang, Hao Shen	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact